[ad_1]
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–59.
Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of mobile senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47–57.
Arden NK, Perry TA, Bannuru RR, Bruyère O, Cooper C, Haugen IK, Hochberg MC, McAlindon TE, Mobasheri A, Reginster J-Y. Non-surgical administration of knee osteoarthritis: comparability of ESCEO and OARSI 2019 pointers. Nat Rev Rheumatol. 2021;17(1):59–66.
Latourte A, Kloppenburg M, Richette P. Rising pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020;16(12):673–88.
Roberts E, Delgado Nunes V, Buckner S, Latchem S, Constanti M, Miller P, Doherty M, Zhang W, Birrell F, Porcheret M, Dziedzic Ok, Bernstein I, Smart E, Conaghan PG. Paracetamol: not as protected as we thought? A scientific literature overview of observational research. Ann Rheum Dis. 2016;75(3):552–9.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM. Cardiovascular security of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–29.
Bally M, Dendukuri N, Wealthy B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. Danger of acute myocardial infarction with NSAIDs in actual world use: bayesian meta-analysis of particular person affected person knowledge. BMJ. 2017;357:j1909.
Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384(1):51–9.
Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays Ok, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J. 2019 American faculty of rheumatology/arthritis basis guideline for the screening, monitoring, and therapy of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol. 2019;71(6):864–77.
Hunter DJ. Viscosupplementation for osteoarthritis of the knee. N Engl J Med. 2015;372(11):1040–7.
Li J, Wang X, Ruan G, Zhu Z, Ding C. Sprifermin: a recombinant human fibroblast progress issue 18 for the therapy of knee osteoarthritis. Skilled Opin Inv Drug. 2021;30(9):923–30.
Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, Reinstrup Bihlet A, Byrjalsen I, Ragnar Andersen J, Eckstein F. Impact of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in sufferers with osteoarthritis: the FORWARD randomized medical trial. JAMA. 2019;322(14):1360–70.
Brett A, Bowes MA, Conaghan PG, Ladel C, Guehring H, Moreau F, Eckstein F. Automated MRI evaluation confirms cartilage thickness modification in sufferers with knee osteoarthritis: post-hoc evaluation from a part II sprifermin research. Osteoarthr Cartil. 2020;28(11):1432–6.
Dahlberg LE, Aydemir A, Muurahainen N, Gühring H, Fredberg Edebo H, Krarup-Jensen N, Ladel CH, Jurvelin JS. A primary-in-human, double-blind, randomised, placebo-controlled, dose ascending research of intra-articular rhFGF18 (sprifermin) in sufferers with superior knee osteoarthritis. Clin Exp Rheumatol. 2016;34(3):445–50.
Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, Antony B, Wang X, Winzenberg T, Blizzard L, Ding C. Impact of vitamin D supplementation on tibial cartilage quantity and knee ache amongst sufferers with symptomatic knee osteoarthritis: a randomized medical trial. JAMA. 2016;315(10):1005–13.
Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL, Smith MD, Brown MT. Tanezumab for the therapy of ache from osteoarthritis of the knee. N Engl J Med. 2010;363(16):1521–31.
Lee B, Parvizi J, Bramlet D, Romness DW, Guermazi A, Noh M, Sodhi N, Khlopas A, Mont MA. Outcomes of a part II research to find out the efficacy and security of genetically engineered allogeneic human chondrocytes expressing TGF-β1. J Knee Surg. 2020;33(02):167–72.
Lu R, Zhang Y, Tao H, Zhou L, Li H, Chen T, Zhang P, Lu Y, Chen S. Gadolinium-hyaluronic acid nanoparticles as an environment friendly and protected magnetic resonance imaging distinction agent for articular cartilage harm detection. Bioact Mater. 2020;5(4):;758-767.
McGonagle D, Baboolal TG, Jones E. Native joint-resident mesenchymal stem cells for cartilage restore in osteoarthritis. Nat Rev Rheumatol. 2017;13(12):719–30.
Hunziker EB, Rosenberg LC. Restore of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am. 1996;78(5):721–33.
Baboolal TG, Mastbergen SC, Jones E, Calder SJ, Lafeber FPJG, McGonagle D. Synovial fluid hyaluronan mediates MSC attachment to cartilage, a possible novel mechanism contributing to cartilage restore in osteoarthritis utilizing knee joint distraction. Ann Rheum Dis. 2016;75(5):908–15.
Chen M, Li Y, Liu S, Feng Z, Wang H, Yang D, Guo W, Yuan Z, Gao S, Zhang Y, Zha Ok, Huang B, Wei F, Sang X, Tian Q, Yang X, sui X, Zhou Y, Zheng Y. Guo Q. Hierarchical macro-microporous WPU-ECM scaffolds mixed with microfracture promote in situ articular cartilage regeneration in rabbits. Bioact Mater. 2021;6(7):1932–44.
Einhorn TA, Gerstenfeld LC. Fracture therapeutic: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45–54.
Makris EA, Gomoll AH, Malizos KN, Hu JC. Athanasiou, restore and tissue engineering methods for articular cartilage. Nat Rev Rheumatol. 2015;11(1):21–34.
Peat G, Thomas MJ. Osteoarthritis 12 months in overview 2020: epidemiology & remedy. Osteoarthr Cartil. 2021;29(2):180–9.
van den Bosch MHJ. Osteoarthritis 12 months in overview 2020: biology. Osteoarthr Cartil. 2021;29(2):143–50.
Gaharwar AK, Singh I, Khademhosseini A. Engineered biomaterials for in situ tissue regeneration. Nat Rev Mater. 2020;5(9):686–705.
Xu C, Chen J, Li L, Pu X, Chu X, Wang X, Li M, Lu Y, Zheng X. Promotion of chondrogenic differentiation of mesenchymal stem cells by copper: implications for brand new cartilage restore biomaterials. Mater Sci Eng C. 2018;93:106–14.
Lu Y, Li L, Lin Z, Wang L, Lin L, Li M, Zhang Y, Yin Q, Li Q, Xia H. A New therapy modality for rheumatoid arthritis: mixed photothermal and photodynamic remedy utilizing Cu7.2S4 nanoparticles. Adv Healthc Mater. 2018;7(14):1800013.
Liu T, Xiao B, Xiang F, Tan J, Chen Z, Zhang X, Wu C, Mao Z, Luo G, Chen X, Deng J. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of irritation associated illnesses. Nat Commun. 2020;11(1):2788.
Cui Z, Crane J, Xie H, Jin X, Zhen G, Li C, Xie L, Wang L, Bian Q, Qiu T, Wan M, Xie M, Ding S, Yu B, Cao X. Halofuginone attenuates osteoarthritis by inhibition of TGF-β exercise and H-type vessel formation in subchondral bone. Ann Rheum Dis. 2016;75(9):1714–21.
Rothenfluh DA, Bermudez H, O’Neil CP, Hubbell JA. Biofunctional polymer nanoparticles for intra-articular focusing on and retention in cartilage. Nat Mat. 2008;7(3):248–54.
Ma Ok, Wang D-D, Lin Y, Wang J, Petrenko V, Mao C. Synergetic focused supply of sleeping-beauty transposon system to mesenchymal stem cells utilizing LPD nanoparticles modified with a phage-displayed focusing on peptide. Adv Funct Mater. 2013;23(9):1172–81.
Trang VH, Zhang X, Yumul RC, Zeng W, Stone IJ, Wo SW, Dominguez MM, Cochran JH, Simmons JK, Ryan MC, Lyon RP, Senter PD, Levengood MR. A coiled-coil masking area for selective activation of therapeutic antibodies. Nat Biotechnol. 2019;37(7):761–5.
Li L, Lu Y, Lin Z, Mao AS, Jiao J, Zhu Y, Jiang C, Yang Z, Peng M, Mao C. Ultralong tumor retention of theranostic nanoparticles with brief peptide-enabled energetic tumor homing. Mater Horiz. 2019;6(9):1845–53.
Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ, Yang HI, Yoo MC. Expression ranges and affiliation of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of sufferers with arthritis. Rheumatol Int. 2011;31(4):543–7.
Ramaraju H, Miller SJ, Kohn DH. Twin-functioning peptides found by phage show improve the magnitude and specificity of BMSC attachment to mineralized biomaterials. Biomaterials. 2017;134:1–12.
Wang M, Sampson ER, Jin H, Li J, Ke QH, Im H-J, Chen D. MMP13 is a crucial goal gene in the course of the development of osteoarthritis. Arthritis Res Ther. 2013;15(1):R5.
Wang B, He X, Zhang Z, Zhao Y, Feng W. Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res. 2013;46(3):761–9.
Lu Y, Li L, Du J, Chen J, Xu X, Yang X, Ding C, Mao C. Immunotherapy for tumor metastasis by synthetic antigen-presenting cells by way of focused microenvironment regulation and T-cell activation. ACS Appl Mater Interfaces. 2021;13(47):55890–901.
Zhang Y, Vasheghani F, Li Y-h, Blati M, Simeone Ok, Fahmi H, Lussier B, Roughley P, Lagares D, Pelletier J-P, Martel-Pelletier J, Kapoor M. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis. 2015;74(7):1432–40.
Huang X, Ni B, Mao Z, Xi Y, Chu X, Zhang R, Ma X, You H. NOV/CCN3 induces cartilage safety by inhibiting PI3K/AKT/mTOR pathway. J Cell Mol Med. 2019;23(11):7525–34.
Zhou X, Li J, Zhou Y, Yang Z, Yang H, Li D, Zhang J, Zhang Y, Xu N, Huang Y, Jiang L. Down-regulated ciRS-7/up-regulated miR-7 axis aggravated cartilage degradation and autophagy defection by PI3K/AKT/mTOR activation mediated by IL-17A in osteoarthritis. Getting older. 2020;12(20):20163–83.
Xu X, Yu H, Solar L, Zheng C, Shan Y, Zhou Z, Wang C, Chen B. Adiposederived mesenchymal stem cells ameliorate dibutyltin dichlorideinduced power pancreatitis by inhibiting the PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 2020;21(4):1833–40.
Xiang J, Jiang T, Zhang W, Xie W, Tang X, Zhang J. Human umbilical cord-derived mesenchymal stem cells enhanced HK-2 cell autophagy by way of MicroRNA-145 by inhibiting the PI3K/AKT/mTOR signaling pathway. Exp Cell Res. 2019;378(2):198–205.
He H, Zeng Q, Huang G, Lin Y, Lin H, Liu W, Lu P. Bone marrow mesenchymal stem cell transplantation exerts neuroprotective results following cerebral ischemia/reperfusion harm by inhibiting autophagy by way of the PI3K/Akt pathway. Mind Res. 2019;1707:124–32.
Xue M, McKelvey Ok, Shen Ok, Minhas N, March L, Park S-Y, Jackson CJ. Endogenous MMP-9 and never MMP-2 promotes rheumatoid synovial fibroblast survival, irritation and cartilage degradation. Rheumatology. 2014;53(12):2270–9.
Hitchon CA, Danning CL, Illei GG, El-Gabalawy HS, Boumpas DT. Gelatinase expression and exercise within the synovium and pores and skin of sufferers with erosive psoriatic arthritis. J Rheumatol. 2002;29(1):107–17.
Chu S-C, Yang S-F, Tzang B-S, Hsieh Y-S, Lue Ok-H, Lu Ok-H. Cathepsin B and cystatin C play an inflammatory position in gouty arthritis of the knee. Clin Chim Acta. 2010;411(21):1788–92.
Makowski GS, Ramsby ML. Zymographic evaluation of latent and activated types of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to an infection. Clin Chim Acta. 2003;329(1):77–81.
[ad_2]
